⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2867338 | 0.78 | — | — | |
| SCHEMBL10998035 | 0.76 | — | — | |
| SCHEMBL12128239 | 0.75 | — | — | |
| SCHEMBL4838834 | 0.75 | — | — | |
| SCHEMBL20085537 | 0.71 | — | — | |
| SCHEMBL9135118 | 0.69 | SMN1; SMN2 (0.33) | — | |
| SCHEMBL29596295 | 0.68 | — | — | |
| SCHEMBL2871130 | 0.68 | — | — | |
| SCHEMBL21064149 | 0.68 | — | — | |
| SCHEMBL471952 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050070515-A1 | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2005-03-31 | — | — | US | disclosed |
| EP-0998484-B1 | METHOD OF IDENTIFYING COMPOUNDS HAVING REDUCED SYSTEMIC EFFECTS | GLAXO GROUP LTD (GB) | 2004-03-03 | — | — | EP | disclosed |
| US-20020019378-A1 | COMPOUNDS | GLAXO WELLCOME INC. | 2002-02-14 | — | — | US | disclosed |
| EP-0998484-A1 | THARAPEUTICALLY ACTIVE COMPOUNDS WITH LOW SYSTEMIC ACTIVITY DUE TO REDUCED HALF-LIFE | GLAXO GROUP LIMITED (GB) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999001467-A2 | THERAPEUTICALLY ACTIVE COMPOUNDS WITH LOW SYSTEMIC ACTIVITY DUE TO REDUCE HALF LIFE | GLAXO GROUP LIMITED (GB) | 1999-01-14 | — | — | WO | disclosed |